Purpose: To develop a technique for joint measurement of fat and water-specific longitudinal relaxation rates (R(1f )and R-1w), effective transverse relaxation rate (R*(2)), and proton density fat fraction (PDFF) combining the Multi-Echo Magnetization Prepared Two Rapid Acquisition of Gradient Echoes (ME-MP2RAGE) sequence and fat-water separation. Theory and methods: All experiments were performed at 3 T. R-1f and R(1w )were calculated with fat-specific and water-specific MP2RAGE signals. R*(2 ) and PDFF maps were obtained from fat-water separation applied to the second RAGE block. Sequence parameters optimization was performed via Cramer-Rao lower bounds theory, and we designed four protocols with different combinations of number of echoes and readout gradient schemes (I: 3 echoes unipolar, II: 6 echoes unipolar, III: 6 echoes bipolar, and IV: 10 echoes bipolar). We tested and validated these protocols with numerical simulations, phantom, and in vivo experiments. In phantoms, we compared ME-MP2RAGE measurements with inversion recovery spin-echo (IR-SE) global R1 and 3D Fast Low Angle Shot (3D FLASH) R*(2 ) and PDFF. In vivo, we scanned the lower leg and neck of a healthy volunteer. Results: Numerical simulations showed accurate quantification of R-1f , R-1w, and R*(2) with mean relative bias <3% and PDFF with mean bias <0.003 using protocol ME-MP2RAGE IV (10 echoes bipolar). Phantom experiments showed excellent agreement with IR-SE and 3D FLASH measurements. In vivo, measurements in the lower leg and neck were consistent with literature values. Conclusion: We proposed an accurate method for simultaneous quantification of R-1f , R-1w , R*(2), and PDFF from a single acquisition with the ME-MP2RAGE sequence.
Background Parental immigration detention is a significant yet understudied stressor with potential consequences for children’s well-being. We examined children’s general health before, during, and after parental detention, and compared to the United States (US) pediatric population. Methods We conducted a cross-sectional household telephone survey in 2022–2023 of family members of immigrants detained by U.S. Immigration and Customs Enforcement in 2020/21 and released on bond. Of 88 respondents, we analyzed data from 49 families with at least one school-aged minor child. Family members retrospectively reported on child health before, during, and after detention using the 7-item parent-report version of the PROMIS® Parent Proxy Scale- Global Health 7 measure, which provides standardized T-scores (mean = 50, SD = 10) benchmarked to the U.S. general population. Findings The mean T-scores were statistically equivalent to the population mean of 50 at pre-detention (49; 95% CI: 46.0, 52.0) and after release (48.9; 95% CI: 45.5, 52.4) but 17 T-score points (∼2 SD below the population mean) lower during detention (31.8; 95% CI: 28.6, 35.0), substantially exceeding the commonly accepted 5 T-score points threshold (half-SD) for clinically meaningful change. Reported problems for children during parental detention included decline in grades (n = 34, 69%), increased financial responsibilities (n = 29, 59%), household or caregiving responsibilities (n = 26, 53%), and food insecurity (n = 26, 53%). About 16% (n = 8) of children were unable to receive needed treatment or counseling from a mental health professional during parental detention. Interpretation Parental detention was associated with poorer reported child health, and reported health scores improved after release. Findings highlight the need for policies that consider the health consequences of immigration enforcement on children and families. Funding This research was supported by the National Science Foundation and the Russell Sage Foundation and the Carnegie Corporation of New York.
Therapeutically engineered stem cells have shown promise for glioblastoma multiforme (GBM) therapy; however, key preclinical studies are urgently needed for their clinical translation. In this study, we investigated a new approach to GBM treatment using therapeutic stem cells encapsulated in biodegradable, synthetic extracellular matrix (sECM) in mouse models of human GBM resection. Using multimodal imaging, we first showed quantitative surgical debulking of human GBM tumors in mice, which resulted in increased survival. Next, sECM encapsulation of engineered stem cells increased their retention in the tumor resection cavity, permitted tumor-selective migration and release of diagnostic and therapeutic proteins in vivo. Simulating the clinical scenario of GBM treatment, the release of tumor-selective S-TRAIL (secretable tumor necrosis factor apoptosis inducing ligand) from sECM-encapsulated stem cells in the resection cavity eradicated residual tumor cells by inducing caspase-mediated apoptosis, delayed tumor regrowth and significantly increased survival of mice. This study demonstrates the efficacy of encapsulated therapeutic stem cells in mouse models of GBM resection and may have implications for developing effective therapies for GBM.
This review describes the complex relationships between depression, anxiety, and bipolar disorder with atherosclerosis by discussing epidemiological evidence, implicated mechanisms, and the impact of psychiatric interventions on cardiovascular outcomes. Depression, anxiety, and bipolar disorder convey independent risk for atherosclerosis. Further, the presence of cardiovascular disease often contributes to worsened psychiatric symptoms. Current evidence supports a rising prevalence of psychiatric disorders in association with atherosclerosis and demographic disparities, with stronger links in women and African Americans. Shared biological mechanisms include autonomic dysfunction, hypothalamic-pituitary-adrenal axis overactivity, inflammation, and vascular effects. Pharmacological treatments and behavioral therapies, such as psychotherapy, have the potential to reduce cardiovascular events and improve physiological markers. The expanding understanding of the bidirectional link between depression, anxiety, and bipolar disorder and atherosclerosis calls for integrated care. Early screening and management of these psychiatric disorders may help to slow cardiovascular disease progression.
Disorders of gut-brain interaction (DGBI; formerly known as functional gastrointestinal disorders) are chronic gastrointestinal conditions with no objective biomarker. DGBI such as irritable bowel syndrome and functional dyspepsia are common in eating disorders (EDs) and may maintain ED behaviors including restriction and purging, but DGBI symptoms are not explicitly addressed in standard ED treatments. This review aims to summarize pharmacological, behavioral, and nutritional support interventions for DGBI that may be beneficial in managing DGBI symptoms in individuals with EDs. DGBI symptoms are common in EDs, including shape/weight-motivated EDs (e.g., anorexia nervosa) and in avoidant/restrictive food intake disorder. Theoretical work supports bi-directional risk. While evidence-based treatments for DGBI symptoms are available, there is limited research on treatment of DGBI within the context of an ED. Neuromodulator medications, brain-gut behavioral therapies (BGBTs), and nutritional support may help manage DGBI symptoms in EDs, but currently only retrospective chart reviews and case studies support this approach. DGBI symptoms are frequently present in patients with EDs and could be an important maintaining factor for ED symptoms but further prospective research is needed. DGBI management techniques have not been well-studied in ED populations. Future research may consider adapting interventions for DGBI in ED populations.